During the past decade, Los Angeles Clinical Trials conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Los Angeles Clinical Trials" #1 sponsor was "GlaxoSmithKline" with 3 trials, followed by "British American Tobacco (Investments) Limited" with 2 trials sponsored, "Achieve Life Sciences" with 1 trials sponsored, "Altria Client Services LLC" with 1 trials sponsored and "Arizona State University" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Los Angeles Clinical Trials" #1 collaborator was "LA Clinical Trials" with 3 trials as a collaborator, "Los Angeles Clinical Trials" with 2 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "Battelle Memorial Institute" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Los Angeles Clinical Trials" are "Smoking Cessation" (4 trials), "Smoking" (3 trials), "Electronic Cigarette Use" (2 trials), "Healthy Volunteers" (2 trials) and "Tobacco Dependence" (2 trials). Many other conditions were trialed in "Los Angeles Clinical Trials" in a lesser frequency.

Most popular intervention types in "Los Angeles Clinical Trials" are "Drug" (7 trials), "Other" (6 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Use electronic cigarette or smoke conventional cigarette" (2 trials), "0.0mg placebo Varenicline b.i.d." (1 trials), "0.5mg Varenicline b.i.d." (1 trials) and "1.0mg Varenicline b.i.d." (1 trials). Other intervention names were less common.

The vast majority of trials in "Los Angeles Clinical Trials" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Los Angeles Clinical Trials". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Los Angeles Clinical Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Los Angeles Clinical Trials, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".